Asia-Pacific mitral and tricuspid valve replacement registry
Part of Heart & circulation clinical trials.
This study collects information from patients in the Asia-Pacific region who have had or plan to have a procedure to replace a failing mitral or tricuspid valve with a new valve placed inside the old one (called valve-in-valve) or inside a ring that was used in a previous repair (valve-in-ring). The goal is to learn more about how well these procedures work and how they can be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older
- You have had or plan to have a mitral or tricuspid valve-in-valve or valve-in-ring procedure
- You do not have an active infection of the heart valve (endocarditis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with leaky or narrowed heart valves who are being considered for a valve procedure. It helps doctors better understand patient outcomes and care decisions for these valve problems.
This study looks at how well a new valve works when placed inside a previous mitral or tricuspid valve repair or replacement. It may help people who need another procedure on these heart valves.
This study is a registry (a way to track real-world outcomes) for people with mitral valve disease who receive a mitral valve procedure. It helps doctors understand how well these procedures work and what complications happen in patients like you.
This study is a registry that collects data on patients who receive a new type of heart valve replacement for the tricuspid valve through a less invasive catheter procedure. Joining helps doctors learn more about how well this treatment works in real-world patients.
This study keeps a registry of adults who have a mitral valve problem and are being evaluated for a catheter-based mitral valve replacement. It helps doctors understand what treatments are used and how patients do.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
Hear when a new Structural Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.